Clinical Trials for NeoGenomics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: NeoGenomics

Clinical Trials (2)

NCT05414032
Molecular Residual Disease Interception in Locoregionally-Advanced High Risk HPV+ and HPV- HNSCC
PHASE2Recruiting
200 participants
Started: Jul 12, 2023 · Completed: Jul 31, 2026
1 condition3 sponsors1 location
NCT05077709
IO102-IO103 in Combination With Pembrolizumab as First-line Treatment for Patients With Metastatic NSCLC, SCCHN, or mUBC
PHASE2Active, not recruiting
63 participants
Started: Feb 14, 2022 · Completed: Nov 30, 2024
3 conditions5 sponsors21 locations